Busulphan lung in childhood

Area of Science:

• Oncology
• Pulmonology
• Pharmacology

Background:

• Busulphan is a chemotherapy agent used for chronic myeloid leukaemia.
• Long-term busulphan treatment can lead to serious adverse effects.
• Early detection of complications is crucial for patient management.

Observation:

• A pediatric patient with chronic myeloid leukaemia showed initial positive response to busulphan.
• After four years, the patient developed 'busulphan lung', a serious pulmonary complication.
• Pulmonary function tests (PFT) were employed during monitoring.

Findings:

• Busulphan treatment, while effective, carries a risk of developing busulphan lung.
• Pulmonary function tests demonstrated utility in tracking the progression of this condition.
• The case highlights a specific adverse event associated with prolonged busulphan use.

Implications:

• Regular pulmonary function testing should be considered for patients undergoing long-term busulphan therapy.
• This monitoring strategy may aid in the early identification and management of busulphan lung.
• Further research into the mechanisms and prevention of busulphan lung is warranted.